Genetic Syndromes Part 2

Dive into the intriguing world of genetic syndromes that elevate cancer risk, particularly focusing on renal cell carcinoma. Learn about the critical roles of syndromes like von Hippel-Lindau and the promising drug Belzutafan. Discover how genetic mutations influence cancer risks and unique clinical manifestations. The discussion highlights the importance of early detection and intervention in conditions like Hereditary Leiomyomatosis. Plus, gain insights into germline testing for solid tumors and its impact on effective risk management.